| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 11/06/2001 | US6313277 Breast cancer resistance protein (BCRP) and the DNA which encodes it |
| 11/06/2001 | US6313276 Human endothelin receptor |
| 11/06/2001 | US6313272 Nucleotide sequence coding geneticaly engineered protein; for treatment of autoimmune diseases |
| 11/06/2001 | US6313271 OCT-3 polypeptides |
| 11/06/2001 | US6313269 Tumor necrosis factor related receptor, TR6 |
| 11/06/2001 | US6313267 Calcium-binding proteins |
| 11/06/2001 | US6313266 Amino acid sequence of polypeptide which binds histone h1; diagnosis, treatment, and prevention of cancer, autoimmune disorders, and alzheimer's disease; anticarcinogenic agents |
| 11/06/2001 | US6313265 Protein associated with neuronal projections; for use in treatment of nervous system injuries; for use in nervous system regeneration |
| 11/06/2001 | US6313264 Effector proteins of Rapamycin |
| 11/06/2001 | US6313263 γ, δ T cell receptor and methods for detection |
| 11/06/2001 | US6313146 Calcium receptor-active molecules |
| 11/06/2001 | US6313103 Pectic substance as a growth factor stabilizer |
| 11/06/2001 | US6313092 Method for increasing the electrotransport flux of polypeptides |
| 11/06/2001 | US6313091 Pharmaceutical compositions containing TSG-6 for treating inflammatory diseases and cancer-related pathologies and method |
| 11/06/2001 | US6312957 Genetic modification of primate hemopoietic repopulating stem cells |
| 11/06/2001 | US6312949 Cell having exogenous nucleic acid which codes for an amino acid sequence which activates tyrosine hydroxylase expression; treatment of parkinson's disease, manic depression, and schizophrenia |
| 11/06/2001 | US6312947 Nucleotide sequences coding nematode polypeptide; for use in prevention of apoptosis; for use in treating viral and parasitic infections |
| 11/06/2001 | US6312946 Viable contaminant particle free adenoviruses, their prepartion and use |
| 11/06/2001 | US6312945 Human glutamate receptor proteins and associated DNA compounds |
| 11/06/2001 | US6312944 Nucleotide sequences coding microorganism poylpeptide; fo r use as diagnostic tool in genetic engineering |
| 11/06/2001 | US6312941 Compositions and methods for identifying signaling pathway agonists and antagonists |
| 11/06/2001 | US6312939 Cells; for use in treatment of tumors, lung, breast and colon cancer and the treatment of preferential viral diseases |
| 11/06/2001 | US6312937 Amino acid sequence which encodes a tumor necrosis factor-alpha converting enzyme-like protein and a matrilysin-like protein; diagnosis of cancer; anticarcinogenic agents |
| 11/06/2001 | US6312929 Compositions and methods enabling a totally internally controlled amplification reaction |
| 11/06/2001 | US6312927 Removing preferential terminal messenger ribonucleic acid sequences; provide nucleotide sequences, generate complementary sequences, tie terminals, amplify, cleave preferential terminal sequences |
| 11/06/2001 | US6312924 Nucleotide sequences coding polypeptides for use in the treatment and diagnosis of autoimmune diseases, cancers and infections |
| 11/06/2001 | US6312923 Method for expression of heterologous proteins in yeast |
| 11/06/2001 | US6312922 Complementary DNAs |
| 11/06/2001 | US6312921 Nucleotide sequences which code preferential polyeptides; for use in diagnosis and treatment of tumors |
| 11/06/2001 | US6312920 Nucleotide sequences coding enzymatic polypeptide; for use in the generation of tylosins |
| 11/06/2001 | US6312916 Mutant polypeptide; for use in reduction of inteference associated with immunoassays |
| 11/06/2001 | US6312915 Tick (Ixodes scapularis) vector saliva-induced Lyme disease spirochete (Borrelia burgdorferi) antigens as vaccine candidates |
| 11/06/2001 | US6312912 Detecting regulatory preferential sequences; measure expression of heterologous nucleotide sequence in presence and absence of preferential regulatory sequences, compare to control, amplified expression indicates regulatory sequences |
| 11/06/2001 | US6312909 Compositions and methods for the diagnosis prevention and treatment of tumor progression |
| 11/06/2001 | US6312907 An isolated nucleic acid encoding a gene for decorin binding protein from borrelia; diagnosis and therapy of lyme disease in humans and animals |
| 11/06/2001 | US6312899 A polynucleotide probe for the detection and diagnositic staging of lymphocyte differentiation |
| 11/06/2001 | US6312895 A method for detecting binding proteins by forming hybridization complexes as an indicator of the presence of the polynucleotide encoding the binding protein |
| 11/06/2001 | US6312892 High fidelity detection of nucleic acid differences by ligase detection reaction |
| 11/06/2001 | US6312890 Partial intron sequence of von hippel-lindau (VHL) disease gene and its use in diagnosis of disease |
| 11/06/2001 | US6312889 A mixture antigens that have a broader range for use in an immunoassay; the mixture has antigens from the c domain, the ns3, ns4, ns5 or the s domain of the viral protein and form a fusion protein; diagnostic kit |
| 11/06/2001 | US6312887 Obtaining atomic coordinates by defining a three dimensional crystal structure of a transcription factors that diffracts x-rays, selecting drug compounds that bind the protein; drug screening |
| 11/06/2001 | US6312733 Antigrowth agents |
| 11/06/2001 | US6312699 Genetic engineering of adenoviral fiber protein with caboxy end group |
| 11/06/2001 | US6312696 Isolated dna molecules with polypeptide codes and amino acid sequences |
| 11/06/2001 | US6312695 Isolated polypeptide with given sequence |
| 11/06/2001 | US6312693 Antibodies against human CD40 |
| 11/06/2001 | US6312692 Method of treating graft-versus-host disease with anti-GP39 antibodies and bone marrow cells |
| 11/06/2001 | US6312691 Treating tumors |
| 11/06/2001 | US6312681 Compositions and methods for the treatment of cancer using recombinant viral vector delivery systems |
| 11/06/2001 | US6312680 Antiarthritic agents and rheumatic agents |
| 11/06/2001 | US6312664 Biodegradable contrast media for MR imaging |
| 11/06/2001 | CA2032559C Endothelin antagonistic cyclic pentapeptides |
| 11/05/2001 | CA2307709A1 Two human g-protein coupled receptors: ebv-induced gpcr 2(ebi-2) and edg-1-like gpcr |
| 11/01/2001 | WO2001081918A1 Transcriptionally regulated g protein-coupled receptor g2a |
| 11/01/2001 | WO2001081634A2 Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941 |
| 11/01/2001 | WO2001081629A1 Diagnostic and therapeutic methods using the h37 tumor suppressor gene |
| 11/01/2001 | WO2001081622A2 Diagnosis of diseases associated with dna repair |
| 11/01/2001 | WO2001081609A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 11/01/2001 | WO2001081607A2 Adenovirus vectors with knobless fibers, and their uses |
| 11/01/2001 | WO2001081602A2 Mre11 orthologue and uses thereof |
| 11/01/2001 | WO2001081601A2 Manipulation of min genes in plants |
| 11/01/2001 | WO2001081599A2 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors |
| 11/01/2001 | WO2001081594A1 A novel polypeptide, a human pax protein 17 and the polynucleotide encoding the polypeptide |
| 11/01/2001 | WO2001081593A1 Novel polypeptide-a humanic protein 20 containing paired box domain and polynucleotide encoding it |
| 11/01/2001 | WO2001081585A2 A thymus expressed human cytochrome p450 (p450tec) |
| 11/01/2001 | WO2001081582A2 Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same |
| 11/01/2001 | WO2001081581A2 Compositions and methods for the therapy and diagnosis of acne vulgaris |
| 11/01/2001 | WO2001081580A1 Origin of replication in the hyperthermophilic pyrococcus archea and its applications |
| 11/01/2001 | WO2001081578A2 Novel proteins and nucleic acids encoding same |
| 11/01/2001 | WO2001081577A2 Dna encoding the prost 03 polypeptide |
| 11/01/2001 | WO2001081576A2 Novel g protein-coupled receptor con-218 |
| 11/01/2001 | WO2001081574A2 Regulation of nf-at interacting protein nip 45 variant |
| 11/01/2001 | WO2001081573A1 Edg8 receptor, its preparation and use |
| 11/01/2001 | WO2001081572A1 A novel polypeptide, a human renal cancer rage4 antigen 25 and the polynucleotide encoding the polypeptide |
| 11/01/2001 | WO2001081571A1 A novel polypeptide, a human protein 11 containing g protein coupling receptor conserved region and the polynucleotide encoding the polypeptide |
| 11/01/2001 | WO2001081570A2 Heteromultimeric ion channel receptor and uses thereof |
| 11/01/2001 | WO2001081562A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof |
| 11/01/2001 | WO2001081554A1 Pneumovirus ns proteins antagonising the interferon (ifn) response |
| 11/01/2001 | WO2001081553A1 Alphavirus-based vectors for persistent infection |
| 11/01/2001 | WO2001081548A1 Novel cell systems having specific interaction of peptide binding pairs |
| 11/01/2001 | WO2001081547A2 Identification, cloning and characterization of a novel pc-1 gene differentially expressed in prostate cells and tissues |
| 11/01/2001 | WO2001081546A2 CeSERT GENES, PROTEINS, AND MODULATORY COMPOUNDS |
| 11/01/2001 | WO2001081545A2 Regulation of gene expression by hspbp1 |
| 11/01/2001 | WO2001081544A2 Identification and uses of a hyaluronan receptor |
| 11/01/2001 | WO2001081540A2 Growth factor which acts through erb b-4 rtk |
| 11/01/2001 | WO2001081539A2 A novel polypeptide, a human zinc ion transport protein 26 and the polynucleotide encoding the polypeptide |
| 11/01/2001 | WO2001081538A2 A novel polypeptide, a human connexin 9 and the polynucleotide encoding the polypeptide |
| 11/01/2001 | WO2001081535A2 A novel polypeptide, a human pax protein 9.9 and the polynucleotide encoding the polypeptide |
| 11/01/2001 | WO2001081427A1 A reporter protein construct, partly comprising gpf |
| 11/01/2001 | WO2001081426A2 Rgd (arg-gly-asp) coupled to (neuro)peptides |
| 11/01/2001 | WO2001081421A2 Synthetic peptides that bind to the hepatitis b virus core and e antigens |
| 11/01/2001 | WO2001081420A1 A novel polypeptide, a laminin 19 and the polynucleotide encoding the polypeptide |
| 11/01/2001 | WO2001081419A1 A novel polypeptide, a human beta-globulin control factor 10 and the polynucleotide encoding the polypeptide |
| 11/01/2001 | WO2001081418A1 New neuromedin u receptor nmur2 and nucleotides encoding it |
| 11/01/2001 | WO2001081417A2 Use of taci as an anti-tumor agent |
| 11/01/2001 | WO2001081416A2 Human ion channel and uses thereof |
| 11/01/2001 | WO2001081415A2 Parathyroid hormone and parathyroid hormone-related protein antagonists |
| 11/01/2001 | WO2001081414A2 Integrin alpha subunit and uses thereof |
| 11/01/2001 | WO2001081413A2 Isolated human transporter proteins, nucleic acids and uses thereof |
| 11/01/2001 | WO2001081412A2 Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof |